Wang Z, Hoffert Y, Zhang W, Kantasiripitak W, et al. Infliximab and ustekinumab clearance better predict endoscopic outcomes than trough concentrations in Crohn's disease. Clin Gastroenterol Hepatol 2025 Sep 7:S1542-3565(25)00750.
PMID: 40925517